Remittix has moved into the final stage of its presale after launching an updated website and confirming ongoing discussions with major centralized exchanges, signaling a transition toward the next phase of its rollout.
Latest articles by Krasimir Rusev
IPO Genie $IPO advances through Phase 82 with reported holder growth and 1.5 million USD raised. Overview of the presale crypto project as of April 2026
Analysis of selected crypto assets including BDAG, XRP, BNB, and Hyperliquid, highlighting utility, adoption, and market activity.
Track major crypto developments this week as Ethereum tests resistance levels, Hyperliquid shows derivatives-driven activity, and BlockDAG outlines upcoming platform and listing milestones.
Discover how AI-powered education improves cryptocurrency market understanding, analysis, and learning. Explore Masterly AI as a tool for smarter financial education and insights.
FanDuel holds 41% of the US betting market, DraftKings reports profitability, Betway exits the US, 1xBet expands sponsorships, and Spartans.com reports $1B in beta activity.
Explore Cardano and Monero price trends and how Spartans.com reported $1B in beta wagers ahead of its August 1, 2026, global launch.
Analyze the next big crypto alongside the latest Dogecoin price trends and the Ethereum price forecast for 2026, as BlockDAG approaches key exchange listings.
Spartans.com's multi-million dollar RAF partnership redefines what a sports betting site can look like in 2026. How does it compare to Rainbet and Shuffle right now?
Explore Q2 2026 crypto presales with IPO Genie as a leading candidate. Assess risks, potential rewards, and key factors for early-stage investments.
Investors are exploring new approaches to Bitcoin participation. Learn how Bitcoin Everlight (BTCL) introduces a shard system designed to provide access to BTC-based rewards without traditional mining requirements.
IPO Genie reports 12.71B tokens sold, 2,291 holders, and Phase 85 live as interest grows around private market tokenization and AI-assisted pre-IPO research access.